Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi:10.3390/nu17132164 Pivari F, Mingione A, Piazzini G, et al
A critical finding from independent peptide testing: GLP-1 receptor agonists and related peptides show the highest discrepancy rates of any peptide category, with only 27% of supplier-provided COAs exactly matching independent laboratory results
Ipamorelin holds no Health Canada human or veterinary use authorization, so administering the peptide to a person or animal would step outside that designation
Review contraindications against your own history: Medullary thyroid carcinoma family history, MEN 2 syndrome, pancreatitis history, severe GI or kidney disease, pregnancy, breastfeeding - if any of these apply, discuss with your own physician before starting the intake
